Acute coronary syndrome
RecruitingStudy on Reducing Antiplatelet Therapy in Patients with Acute Coronary Syndrome and High Bleeding Risk Using Prasugrel, Ticagrelor, or Clopidogrel
Study on Reducing Antiplatelet Therapy in Patients with Acute Coronary Syndrome and High Bleeding Risk Using Prasugrel, Ticagrelor, or Clopidogrel
- Disease:Acute coronary syndrome
- Substances:Acetylsalicylic Acid
Italy- Participants:18–64 years · 65+ years
- Substances:Acetylsalicylic Acid
- Sponsor:Azienda Ospedaliera Universitaria Gaetano Martino Messina

